Works matching IS 03057453 AND DT 2023 AND VI 78 AND IP 12


Results: 35
    1

    Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trial.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2995, doi. 10.1093/jac/dkad344
    By:
    • Mazouz, Fella;
    • Bertine, Mélanie;
    • Coppée, Romain;
    • Storto, Alexandre;
    • Katlama, Christine;
    • Landman, Roland;
    • Cabié, André;
    • Peytavin, Gilles;
    • Raffi, François;
    • Yazdanpanah, Yazdan;
    • Descamps, Diane;
    • Joly, Véronique;
    • Ghosn, Jade;
    • Charpentier, Charlotte;
    • Group, the LAMIDOL Study
    Publication type:
    Article
    2

    Acknowledgement of referees.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 3013, doi. 10.1093/jac/dkad343
    Publication type:
    Article
    3
    4
    5
    6

    Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2961, doi. 10.1093/jac/dkad338
    By:
    • Rocabert, Alba;
    • Borjabad, Beatriz;
    • Berrocal, Leire;
    • Blanch, Jordi;
    • Inciarte, Alexy;
    • Chivite, Ivan;
    • Gonzalez-Cordon, Ana;
    • Torres, Berta;
    • Ambrosioni, Juan;
    • Martinez-Rebollar, Maria;
    • Laguno, Montserrat;
    • Mora, Lorena De La;
    • Foncillas, Alberto;
    • Sempere, Abiu;
    • Rodriguez, Ana;
    • Solbes, Estela;
    • Llobet, Roger;
    • Miro, Jose M;
    • Mallolas, Josep;
    • Blanco, Jose L
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2919, doi. 10.1093/jac/dkad331
    By:
    • Hervochon, Charles;
    • Hennart, Benjamin;
    • Leroy, Anne-Gaëlle;
    • Corvec, Stéphane;
    • Boutoille, David;
    • Senneville, Éric;
    • Sotto, Albert;
    • Illes, Gabriella;
    • Chavanet, Pascal;
    • Dubée, Vincent;
    • Bleibtreu, Alexandre;
    • Carné, Marie-Charlotte De;
    • Talarmin, Jean-Philippe;
    • Revest, Matthieu;
    • Castan, Bernard;
    • Bellouard, Ronan;
    • Dailly, Éric;
    • Allorge, Delphine;
    • Dinh, Aurélien;
    • Turnier, Paul Le
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2859, doi. 10.1093/jac/dkad319
    By:
    • Uno, Shunsuke;
    • Gatanaga, Hiroyuki;
    • Hayashida, Tsunefusa;
    • Imahashi, Mayumi;
    • Minami, Rumi;
    • Koga, Michiko;
    • Samukawa, Sei;
    • Watanabe, Dai;
    • Fujii, Teruhisa;
    • Tateyama, Masao;
    • Nakamura, Hideta;
    • Matsushita, Shuzo;
    • Yoshino, Yusuke;
    • Endo, Tomoyuki;
    • Horiba, Masahide;
    • Taniguchi, Toshibumi;
    • Moro, Hiroshi;
    • Igari, Hidetoshi;
    • Yoshida, Shigeru;
    • Teshima, Takanori
    Publication type:
    Article
    24
    25
    26

    Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2840, doi. 10.1093/jac/dkad316
    By:
    • Bock, Magnus;
    • Hasselt, Johan G C Van;
    • Schwartz, Franziska;
    • Wang, Hengzhuang;
    • Høiby, Niels;
    • Fuursted, Kurt;
    • Ihlemann, Nikolaj;
    • Gill, Sabine;
    • Christiansen, Ulrik;
    • Bruun, Niels Eske;
    • Elming, Hanne;
    • Povlsen, Jonas A;
    • Køber, Lars;
    • Høfsten, Dan E;
    • Fosbøl, Emil L;
    • Pries-Heje, Mia M;
    • Christensen, Jens Jørgen;
    • Rosenvinge, Flemming S;
    • Torp-Pedersen, Christian;
    • Helweg-Larsen, Jannik
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33

    Real-world experience of therapeutic drug monitoring and PK/PD achievement of ceftaroline administered by different infusion regimens in patients with confirmed infections caused by Gram-positive bacteria.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2810, doi. 10.1093/jac/dkad296
    By:
    • Fresán, Daniel;
    • Luque, Sonia;
    • Benítez-Cano, Adela;
    • Sorlí, Luisa;
    • Montero, María Milagro;
    • De-Antonio, Marta;
    • Vega, Victoria;
    • Roberts, Jason A;
    • Horcajada, Juan P;
    • Grau, Santiago
    Publication type:
    Article
    34
    35